mardi 30 mai 2017

Onco Actu du 30 mai 2017

4.1 Dép., diag. & prono. - Prostate

Medicare Coverage of Prolaris® Test Expands with the Addition of Men Diagnosed with Favorable Intermediate Risk Prostate Cancer [Myriad]

5.12 Immunothérapies

A Brain Tumor Kept at Bay by Immunotherapy [Dana-Farber Cancer Institute]

5.12.2 Immunothérapies - CAR-T

Celyad obtains additional US patent for cancer treatment based on TCR-deficient allogeneic CAR-T cells [Celyad]

5.3 Traitements - FDA, EMA, NICE...

NICE Terminates Technology Appraisal for Afatinib in Advanced Squamous NSCLC After Platinum-based Chemotherapy [ESMO]

5.4 Traitements - Economie

A Look at Major Drug-Pricing Proposals [NY Times]

Drug Lobbyists’ Battle Cry Over Prices: Blame the Others [NY Times]

6. Lutte contre les cancers

Amid Budget Concerns, NIH Preps Beta Test for Precision Medicine Plan [Xconomy]

The trauma of a breast cancer diagnosis can have cognitive effects [Reuters]

6.10 Politiques

Report reveals benefits of EU-UK medical research partnerships [Cancer Research UK]

6.10.1 Politiques (USA)

Trump tweet on health care spending at odds with White House budget [STAT]

6.4 Médico-éco

High-Priced Drugs Raise Costs For Seniors in Medicare Part D [Wall Street Journal]

6.6 Publications

Science Needs a Solution for the Temptation of Positive Results [NY Times]

6.7 DMP, Big Data & applis

Is Big Data Eclipsing the Role of Randomized Controlled Trials? [ISPOR]

Software simplified [Nature]